We have this end to end chain from research that drives definitions of signals and needs. Those things tend to get delivered, in many cases, through mass market types of applications or mass market products. They look at how you take eye-tracking or attention, these biometric data we can deliver, and create insights around people. But when you look at the opportunity we have in front of us, it’s an interesting set of synergies, where we have people who create use cases for our technology in scientific research. For my focus, I’ve come in initially with a view specifically around Tobii Tech, which has been around driving mass market adoption of the technology. I would be the CEO of that new company when we finalize the split, which should happen in the Q4 time frame. The remaining company retaining the name of Tobii would be that group function with these two divisions underneath. Dynavox will be a stand-alone company that’s listed on the Stockholm NASDAQ. We’re going to list the Dynavox division separately. What the company announced at the end of April was that we were going to split the company into two pieces.
#Alienware eye tracking Pc#
We’ve focused on PC and VR and a couple of other adjacent vertical areas.
#Alienware eye tracking software#
We do of course create higher value offerings in the software space, but in the broadest sense, we’re trying to proliferate the adoption of our technology in mass market opportunities. We’re more like a picks and shovels company. The division I’ve been running for the last couple of years is Tobii Tech.
#Alienware eye tracking full#
Both of those divisions do full solution sets that build on top of our core tech. They deliver into universities that are doing research on neuroscience or psychology, but they also deliver that into commercial enterprises who are trying to understand performance, do training, do market research or advertising research.
The second vertical that’s been stood up inside of Tobii is this business called Tobii Pro, which enables us to use eye-tracking to understand human behavior and human preference and performance. They have a lot of value creation focused on delivering medical devices for people who need to communicate. They add software and custom hardware on top of that. One is Tobii Dynavox, which makes medical systems with our underlying core technology. Underneath that we have three relatively independent divisions. The CEO of that is Henrik Eskilsson, who’s been a founder of the company. The company as it’s structured today, there’s the Tobii Group, which is a bit like a holding company. This could give you an idea of how I view the company and the opportunity in front of us. Srivatsa: Maybe I could start out and give you a quick context on the changes happening in the company. VentureBeat: Where is the product line now? Where do you see it going? Our normal business activities have been highly curtailed in the course of the pandemic.
It feels like two years at Tobii have gone by in six months. It was one of the few places where you could still do date night through the entire time. We got there six months before the pandemic started. For this job I ended up moving to Stockholm. When I was at Intel I lived in Oregon for six years. It was an interesting opportunity to be in what I see as the next wave of technology adoption following this human-computer interface, this new modality work. But fundamentally the market is shifting away from desktop computing except in the high end of the space. I think we did some good things on that end. I ended up in desktop, and I was looking for the next opportunity to be more technology-centric. I was on the networking side, the telecom side. At the time it was one of these transformations in my career where I had spent a lot of time in different parts of the business.
When I was at Intel I was running the desktop business, the workstation business, the client computing group. Anand Srivatsa: I spent about 15 years before Tobii at Intel.
0 kommentar(er)
